Ascentage Pharma Group International
- AAPG
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech
- Cancer Therapeutics
$15.60
Today +1.50%Quote Oct 19, 2026, 02:27 PM UTC
0.00%over the last month
Max drawdown −10.8%From 1-month high −5.8%3 months −16.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.82B
Quote Oct 19
Next earnings
Mar 31
Expected, not confirmed
Analyst target
$40.00
+156.4% from here
Floor
$15.02
3.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AAPGPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
767
Founded
2009